Page 21234..1020..»

Category : Nanomedicine

Trending: Oral Contrast Agent Trends, Key Driven Factors, Segmentation And Forecast To 2020-2026 – Bulletin Line

LOS ANGELES, United States: QY Research has recently published a report, titled Global Oral Contrast Agent Market Insights and Forecast to 2026. The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Oral Contrast Agent market. It informs readers about key trends and opportunities in the global Oral Contrast Agent market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Oral Contrast Agent market.

Key companies operating in the global Oral Contrast Agent market include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India) Oral Contrast Agent

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1885992/global-oral-contrast-agent-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Oral Contrast Agent market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Oral Contrast Agent Market Segment By Type:

,Barium-based Contrast Media,Iodinated Contrast Media,Gadolinium-based Contrast Media,Microbubble Contrast Media Oral Contrast Agent

Global Oral Contrast Agent Market Segment By Application:

, Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Oral Contrast Agent market.

Key companies operating in the global Oral Contrast Agent market include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India) Oral Contrast Agent

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1885992/global-oral-contrast-agent-market

TOC

1 Study Coverage1.1 Oral Contrast Agent Product Introduction1.2 Market Segments1.3 Key Oral Contrast Agent Manufacturers Covered: Ranking by Revenue1.4 Market by Type1.4.1 Global Oral Contrast Agent Market Size Growth Rate by Type1.4.2 Barium-based Contrast Media1.4.3 Iodinated Contrast Media1.4.4 Gadolinium-based Contrast Media1.4.5 Microbubble Contrast Media1.5 Market by Application1.5.1 Global Oral Contrast Agent Market Size Growth Rate by Application1.5.2 Cardiovascular Disorders1.5.3 Cancer1.5.4 Gastrointestinal Disorders1.5.5 Musculoskeletal Disorders1.5.6 Neurological Disorders1.5.7 Nephrological Disorders1.6 Study Objectives1.7 Years Considered 2 Executive Summary2.1 Global Oral Contrast Agent Market Size, Estimates and Forecasts2.1.1 Global Oral Contrast Agent Revenue 2015-20262.1.2 Global Oral Contrast Agent Sales 2015-20262.2 Global Oral Contrast Agent, Market Size by Producing Regions: 2015 VS 2020 VS 20262.2.1 Global Oral Contrast Agent Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global Oral Contrast Agent Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Oral Contrast Agent Competitor Landscape by Players3.1 Oral Contrast Agent Sales by Manufacturers3.1.1 Oral Contrast Agent Sales by Manufacturers (2015-2020)3.1.2 Oral Contrast Agent Sales Market Share by Manufacturers (2015-2020)3.2 Oral Contrast Agent Revenue by Manufacturers3.2.1 Oral Contrast Agent Revenue by Manufacturers (2015-2020)3.2.2 Oral Contrast Agent Revenue Share by Manufacturers (2015-2020)3.2.3 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by Oral Contrast Agent Revenue in 20193.2.5 Global Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Oral Contrast Agent Price by Manufacturers3.4 Oral Contrast Agent Manufacturing Base Distribution, Product Types3.4.1 Oral Contrast Agent Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers Oral Contrast Agent Product Type3.4.3 Date of International Manufacturers Enter into Oral Contrast Agent Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026)4.1 Global Oral Contrast Agent Market Size by Type (2015-2020)4.1.1 Global Oral Contrast Agent Sales by Type (2015-2020)4.1.2 Global Oral Contrast Agent Revenue by Type (2015-2020)4.1.3 Oral Contrast Agent Average Selling Price (ASP) by Type (2015-2026)4.2 Global Oral Contrast Agent Market Size Forecast by Type (2021-2026)4.2.1 Global Oral Contrast Agent Sales Forecast by Type (2021-2026)4.2.2 Global Oral Contrast Agent Revenue Forecast by Type (2021-2026)4.2.3 Oral Contrast Agent Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global Oral Contrast Agent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026)5.1 Global Oral Contrast Agent Market Size by Application (2015-2020)5.1.1 Global Oral Contrast Agent Sales by Application (2015-2020)5.1.2 Global Oral Contrast Agent Revenue by Application (2015-2020)5.1.3 Oral Contrast Agent Price by Application (2015-2020)5.2 Oral Contrast Agent Market Size Forecast by Application (2021-2026)5.2.1 Global Oral Contrast Agent Sales Forecast by Application (2021-2026)5.2.2 Global Oral Contrast Agent Revenue Forecast by Application (2021-2026)5.2.3 Global Oral Contrast Agent Price Forecast by Application (2021-2026) 6 North America6.1 North America Oral Contrast Agent by Country6.1.1 North America Oral Contrast Agent Sales by Country6.1.2 North America Oral Contrast Agent Revenue by Country6.1.3 U.S.6.1.4 Canada6.2 North America Oral Contrast Agent Market Facts & Figures by Type6.3 North America Oral Contrast Agent Market Facts & Figures by Application 7 Europe7.1 Europe Oral Contrast Agent by Country7.1.1 Europe Oral Contrast Agent Sales by Country7.1.2 Europe Oral Contrast Agent Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia7.2 Europe Oral Contrast Agent Market Facts & Figures by Type7.3 Europe Oral Contrast Agent Market Facts & Figures by Application 8 Asia Pacific8.1 Asia Pacific Oral Contrast Agent by Region8.1.1 Asia Pacific Oral Contrast Agent Sales by Region8.1.2 Asia Pacific Oral Contrast Agent Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam8.2 Asia Pacific Oral Contrast Agent Market Facts & Figures by Type8.3 Asia Pacific Oral Contrast Agent Market Facts & Figures by Application 9 Latin America9.1 Latin America Oral Contrast Agent by Country9.1.1 Latin America Oral Contrast Agent Sales by Country9.1.2 Latin America Oral Contrast Agent Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina9.2 Central & South America Oral Contrast Agent Market Facts & Figures by Type9.3 Central & South America Oral Contrast Agent Market Facts & Figures by Application 10 Middle East and Africa10.1 Middle East and Africa Oral Contrast Agent by Country10.1.1 Middle East and Africa Oral Contrast Agent Sales by Country10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 U.A.E10.2 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Type10.3 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Application 11 Company Profiles11.1 GE Healthcare (US)11.1.1 GE Healthcare (US) Corporation Information11.1.2 GE Healthcare (US) Description and Business Overview11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered11.1.5 GE Healthcare (US) Related Developments11.2 Bracco Imaging (Italy)11.2.1 Bracco Imaging (Italy) Corporation Information11.2.2 Bracco Imaging (Italy) Description and Business Overview11.2.3 Bracco Imaging (Italy) Sales, Revenue and Gross Margin (2015-2020)11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products Offered11.2.5 Bracco Imaging (Italy) Related Developments11.3 Bayer HealthCare (Germany)11.3.1 Bayer HealthCare (Germany) Corporation Information11.3.2 Bayer HealthCare (Germany) Description and Business Overview11.3.3 Bayer HealthCare (Germany) Sales, Revenue and Gross Margin (2015-2020)11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products Offered11.3.5 Bayer HealthCare (Germany) Related Developments11.4 Guerbet (France)11.4.1 Guerbet (France) Corporation Information11.4.2 Guerbet (France) Description and Business Overview11.4.3 Guerbet (France) Sales, Revenue and Gross Margin (2015-2020)11.4.4 Guerbet (France) Oral Contrast Agent Products Offered11.4.5 Guerbet (France) Related Developments11.5 Lantheus (US)11.5.1 Lantheus (US) Corporation Information11.5.2 Lantheus (US) Description and Business Overview11.5.3 Lantheus (US) Sales, Revenue and Gross Margin (2015-2020)11.5.4 Lantheus (US) Oral Contrast Agent Products Offered11.5.5 Lantheus (US) Related Developments11.6 Daiichi Sankyo (Japan)11.6.1 Daiichi Sankyo (Japan) Corporation Information11.6.2 Daiichi Sankyo (Japan) Description and Business Overview11.6.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products Offered11.6.5 Daiichi Sankyo (Japan) Related Developments11.7 Unijules Life Sciences (India)11.7.1 Unijules Life Sciences (India) Corporation Information11.7.2 Unijules Life Sciences (India) Description and Business Overview11.7.3 Unijules Life Sciences (India) Sales, Revenue and Gross Margin (2015-2020)11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products Offered11.7.5 Unijules Life Sciences (India) Related Developments11.8 J.B. Chemicals and Pharmaceuticals (India)11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information11.8.2 J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview11.8.3 J.B. Chemicals and Pharmaceuticals (India) Sales, Revenue and Gross Margin (2015-2020)11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products Offered11.8.5 J.B. Chemicals and Pharmaceuticals (India) Related Developments11.9 Spago Nanomedicine (Sweden)11.9.1 Spago Nanomedicine (Sweden) Corporation Information11.9.2 Spago Nanomedicine (Sweden) Description and Business Overview11.9.3 Spago Nanomedicine (Sweden) Sales, Revenue and Gross Margin (2015-2020)11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products Offered11.9.5 Spago Nanomedicine (Sweden) Related Developments11.10 Taejoon Pharm (South Korea)11.10.1 Taejoon Pharm (South Korea) Corporation Information11.10.2 Taejoon Pharm (South Korea) Description and Business Overview11.10.3 Taejoon Pharm (South Korea) Sales, Revenue and Gross Margin (2015-2020)11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products Offered11.10.5 Taejoon Pharm (South Korea) Related Developments11.1 GE Healthcare (US)11.1.1 GE Healthcare (US) Corporation Information11.1.2 GE Healthcare (US) Description and Business Overview11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered11.1.5 GE Healthcare (US) Related Developments11.12 Magnus Health (India)11.12.1 Magnus Health (India) Corporation Information11.12.2 Magnus Health (India) Description and Business Overview11.12.3 Magnus Health (India) Sales, Revenue and Gross Margin (2015-2020)11.12.4 Magnus Health (India) Products Offered11.12.5 Magnus Health (India) Related Developments 12 Future Forecast by Regions (Countries) (2021-2026)12.1 Oral Contrast Agent Market Estimates and Projections by Region12.1.1 Global Oral Contrast Agent Sales Forecast by Regions 2021-202612.1.2 Global Oral Contrast Agent Revenue Forecast by Regions 2021-202612.2 North America Oral Contrast Agent Market Size Forecast (2021-2026)12.2.1 North America: Oral Contrast Agent Sales Forecast (2021-2026)12.2.2 North America: Oral Contrast Agent Revenue Forecast (2021-2026)12.2.3 North America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)12.3 Europe Oral Contrast Agent Market Size Forecast (2021-2026)12.3.1 Europe: Oral Contrast Agent Sales Forecast (2021-2026)12.3.2 Europe: Oral Contrast Agent Revenue Forecast (2021-2026)12.3.3 Europe: Oral Contrast Agent Market Size Forecast by Country (2021-2026)12.4 Asia Pacific Oral Contrast Agent Market Size Forecast (2021-2026)12.4.1 Asia Pacific: Oral Contrast Agent Sales Forecast (2021-2026)12.4.2 Asia Pacific: Oral Contrast Agent Revenue Forecast (2021-2026)12.4.3 Asia Pacific: Oral Contrast Agent Market Size Forecast by Region (2021-2026)12.5 Latin America Oral Contrast Agent Market Size Forecast (2021-2026)12.5.1 Latin America: Oral Contrast Agent Sales Forecast (2021-2026)12.5.2 Latin America: Oral Contrast Agent Revenue Forecast (2021-2026)12.5.3 Latin America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa Oral Contrast Agent Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: Oral Contrast Agent Sales Forecast (2021-2026)12.6.2 Middle East and Africa: Oral Contrast Agent Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: Oral Contrast Agent Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key Oral Contrast Agent Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 Oral Contrast Agent Customers14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source16.2 Author Details16.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Read more here:
Trending: Oral Contrast Agent Trends, Key Driven Factors, Segmentation And Forecast To 2020-2026 - Bulletin Line

Recommendation and review posted by Alexandra Lee Anderson

Sirnaomics and Precision NanoSystems Have Formed a Partnership – PRNewswire

Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems' NxGen Platform

GAITHERSBURG, MD andVANCOUVER, BC, June 17, 2020 /PRNewswire/ - Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoAssemblr platform license and supply agreement, plus successful production of multiple batches of Sirnaomics drug product candidates, STP705 and STP707, for ongoing IND enabling safety and toxicity studies, as well as several clinical studies.

Sirnaomics is a clinical stage biopharmaceutical company specialized in RNAi-based therapeutics for addressing the unmet needs in treatment of cancers and fibrosis diseases. The company has developed proprietary polypeptide nanoparticle carriers for efficient siRNA delivery, to advance an enriched drug product pipeline. Sirnaomics' lead product candidate, STP705, is an siRNA (small interfering RNA) therapeutic which takes advantage of a dual-targeted inhibitory property together with a polypeptide nanoparticle (PNP)-enhanced delivery to directly knock down both TGF-1 and COX-2 gene expression. The product candidate has received multiple IND approvals from both the US FDA and Chinese NMPA, including treatments of Cholangiocarcinoma, Non-Melanoma skin cancer and Hypertrophic Scar. STP705 has also received Orphan Drug Designation for treatment of Cholangiocarcinoma, Primary Sclerosing Cholangitis and Hepatocellular Carcinoma. A recent interim analysis report of a phase IIa clinical study on STP705 for treatment of Squamous Cell Carcinoma in situ indicated the topline therapeutic results with complete histological clearance tumor cell on treated sites. Using the same dual targets design, Sirnaomics has further developed STP707, a systemic formulation with broader application potential.

Sirnaomics' founder, president and CEO, Dr. Patrick Lu said, "As the leader in RNAi therapeutics specialized in polypeptide nanoparticle formulation, we are so excited to see the further advancement of our process development and large scale product manufacturing, using PNI's NxGen microfluidic technology. In working with PNI's team and the NanoAssemblr platform, we were able to establish a robust manufacturing process from a nominated drug candidate to GMP manufacturing in just a few months, greatly accelerating our drug development process". Sirnaomics is currently using these batches produced with NxGen for non-human primate safety toxicity studies and clinical studies."

PNI is a global leader in technology solutions to enable the development and manufacture of new nanomedicines in the areas of vaccines, cell therapies and gene therapies for the treatment of oncology, infectious diseases, and rare diseases. With the NanoAssemblr suite of products, PNI provides solutions across the drug development process for clients to develop and seamlessly scale their drug programs. Dr. James Taylor, co-founder and CEO of PNI said, "We are pleased to support Sirnaomics, an innovative RNAi therapeutics company, with our NanoAssemblr platform and Clinical Solutions Team that helped take their drug program to a successful GMP batch manufacture. We believe the NanoAssemblr microfluidic technology enables exquisite control over the particle size, charge and encapsulation efficiency which was important for the performance of Sirnaomics' drug product candidates." PNI's NanoAssemblr platform, with over 400 systems placed worldwide, is designed to enable drug developers to rapidly progress from R&D to industrial-scale nanomedicine manufacture.

About SirnaomicsSirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is a Delaware corporation headquartered in Gaithersburg, Maryland, USA, with subsidiaries in Suzhou and Guangzhou, China. The Company's mission is to develop novel therapeutics to alleviate human suffering and advance patient care in areas of high unmet medical need. The guiding principles of the company are: Innovation, Global Vision with a Patient Centered focus. Members of the senior management team have a great deal of combined experience in the biopharmaceutical industry, financial, clinical and business management in both the USA and China. The company is supported by funding from institutional investors, corporate partnerships and government grants. Sirnaomics has developed a strong portfolio of intellectual property with an enriched product pipeline. The therapeutic areas of focus include oncology and anti-fibrotic therapeutics. Learn more at http://www.sirnaomics.com.

About Precision NanoSystems Inc.Precision NanoSystems Inc. (PNI) proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology. For more information visithttp://www.precisionnanosystems.com.

SOURCE Precision Nanosystems

http://www.precisionnanosystems.com

View original post here:
Sirnaomics and Precision NanoSystems Have Formed a Partnership - PRNewswire

Recommendation and review posted by Alexandra Lee Anderson

Nanobiotix Receives Feedback From US FDA to Advance Phase III Head and Neck Cancer Study Design and CMC Development Plan for NDA – Business Wire

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:

With our recent Fast Track designation for NBTXR3 in this patient population, acceptance of the design of our pivotal phase III trial and agreement on our CMC plan, Nanobiotix is well positioned to deliver on our promise of serving the unmet needs of head and neck cancer patients. Our head and neck cancer pathway is our top priority and these developments represent critical milestones that will allow us to administer and supply our trial. We look forward to taking the necessary steps to initiate NANORAY-312 and evaluate the potential of NBTXR3 to improve treatment outcomes for patients around the world. Laurent Levy, CEO of Nanobiotix.

NANOBIOTIX (Euronext : NANO ISIN : FR0011341205 the Company) (Paris:NANO), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that the FDA has provided necessary feedback regarding the design of NANORAY-312, the Companys pivotal phase III global registration trial in head and neck cancer. The FDA also agreed to the NBTXR3 chemistry, manufacturing, and controls (CMC) Development Plan to support the phase III trial and a future New Drug Application (NDA) for the product.

NANORAY-312: A Phase III Study of NBTXR3 Activated by Investigators Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-based Chemotherapy-ineligible Elderly Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

NANORAY-312 will be a phase III investigators choice, dual-arm, randomized (1:1) global registration trial including elderly head and neck cancer patients who are ineligible for platinum-based chemotherapy.

Patients in the control arm will receive radiation therapy with or without cetuximab (investigators choice), and patients in the treatment arm will receive NBTXR3 activated by radiation therapy with or without cetuximab (investigators choice).

The trial is expected to recruit approximately 500 patients. A futility analysis is expected 18 months after the first patient in the trial is randomized, and the interim analysis for progression-free survival (PFS) superiority is expected at 24-30 months. The final analysis will report on PFS and overall survival. Quality of Life will also be measured as a key secondary outcome. In the event of favorable data from the interim analysis, the FDA has advised that NBTXR3 could potentially qualify for accelerated approval.

In support of the phase III trial and a future NBTXR3 New Drug Application (NDA), Nanobiotix met with the FDA in a Type B end-of-phase I meeting on October 16, 2019. Following additional correspondence with the FDA, including written responses to the FDAs recommendations, the Company received written FDA guidance on April 3, 2020. The Company expects to commence NANORAY-312 after making protocol refinements and securing the requisite financing to fund the trial.

Agreement to CMC Development Plan

The FDAs written response regarding the CMC Development Plan does not raise any safety concerns for continued clinical development of NBTXR3, and the FDA agreed to the updated CMC Plan for NBTXR3 during an ongoing phase III clinical trial.

***

About NBTXR3NBTXR3 is a first-in-class product designed to destroy tumors through physical cell death when activated by radiotherapy. NBTXR3 has a high degree of biocompatibility, requires one single administration before the first radiotherapy treatment session, and has the ability to fit into current worldwide standards of radiation care. The physical mode of action of NBTXR3 makes it applicable across solid tumors.

NBTXR3 is actively being evaluated in clinical trials worldwide as a potential treatment in various cancer indications. The Company is prioritizing the development of NBTXR3 in the United States and the EU for the treatment of patients with locally advanced head and neck cancers ineligible for chemotherapy.

Nanobiotix is also running an Immuno-Oncology development program, evaluating NBTXR3 activated by radiotherapy as a primer of immune response in combination with checkpoint inhibitors. The Company has launched a phase I clinical trial of NBTXR3 activated by radiotherapy in combination with anti-PD-1 checkpoint inhibitors in patients with locoregional recurrent (LRR) or recurrent and metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) amenable to re-irradiation or with lung or liver metastasis (mets) from any primary cancer eligible for anti-PD-1 therapy.

Other ongoing NBTXR3 trials are treating patients with liver cancers (hepatocellular carcinoma and liver metastasis), locally advanced or unresectable rectal cancer in combination with chemotherapy, head and neck cancer in combination with concurrent chemotherapy, and pancreatic cancer. The Company has a broad, comprehensive clinical research collaboration with The University of Texas MD Anderson Cancer Center (initially expected to support nine new clinical trials in the United States) to evaluate NBTXR3 across several cancer types.

About NANOBIOTIX: http://www.nanobiotix.com Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges.

Nanobiotixs first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotixs Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Companys headquarters are in Paris, France, with a US affiliate in Cambridge, MA, and European affiliates in France, Spain and Germany.

Disclaimer

This press release contains certain forward-looking statements concerning Nanobiotix and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Nanobiotix considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the universal registration document of Nanobiotix registered with the French Financial Markets Authority (Autorit des Marchs Financiers) under number R.20-010 on May 12, 2020 (a copy of which is available on http://www.nanobiotix.com) and to the development of economic conditions, financial markets and the markets in which Nanobiotix operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Nanobiotix or not currently considered material by Nanobiotix. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Nanobiotix to be materially different from such forward-looking statements.

Excerpt from:
Nanobiotix Receives Feedback From US FDA to Advance Phase III Head and Neck Cancer Study Design and CMC Development Plan for NDA - Business Wire

Recommendation and review posted by Alexandra Lee Anderson

Global Healthcare Nanotechnology (Nanomedicine) Market 2020 with (Covid-19) Impact Analysis: Business Outlook, Future Growth and Regional Forecasts…

Researchstore.biz, after comprehensive analysis, has introduced a new research study titled Global Healthcare Nanotechnology (Nanomedicine) Market 2020 by Company, Type and Application, Forecast to 2025, which highlights developments, industry challenges that competitors are facing along with gaps and opportunities available in the market. The report includes the data about the product in the market, marketing patterns pursued by the business, top players, up and coming trends. The report provides an assessment of the market and contains important insights, historical data, and industry-validated market data. The report covers market evolution, overview, value chain, trade scenario, market size, market segmentation, and competitive scenario. Information as per the market segments such as geographies, products, technologies, applications is given in the report.

The report presents insightful analyses of the market and has a comprehensive understanding of the global Healthcare Nanotechnology (Nanomedicine) market industry analysis and forecast 2020-2025 and its commercial landscape. Critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics. The complete value chain and downstream and upstream essentials are scrutinized in this report. It additionally seriously explored the global Healthcare Nanotechnology (Nanomedicine) market development pattern based on regional order. Marketing strategies and different channels have been listed here.

DOWNLOAD FREE SAMPLE REPORT: https://www.researchstore.biz/sample-request/47548

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Key companies profiled in the market report are Amgen, Merck & Co, UCB, Teva Pharmaceuticals, Sanofi, Abbott, Stryker, Celgene, Roche, Biogen, SmitH& Nephew, Takeda, Gilead Sciences, Endo International, Leadiant Biosciences, Johnson & Johnson, Pfizer, Ipsen, Kyowa Hakko Kirin, 3M Company, and more in terms of company basic information, product introduction, application, specification, production, revenue, price and gross margin (2015-2020), etc.

Differentiation of the market based on types of product: Nanomedicine, Nano Medical Devices, Nano Diagnosis, Other

Differentiation of the market based on types of its application: Anticancer, CNS Product, Anti-infective, Other

Geographically, this report studies the top producers and consumers in these key regions: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa). Here each geographic segment of the Healthcare Nanotechnology (Nanomedicine) market has been independently investigated along with pricing, distribution, and demand data for geographic market.

What Insights Does The Healthcare Nanotechnology (Nanomedicine) Market Report Provide To The Readers?

Moreover, the report focuses on the key global Healthcare Nanotechnology (Nanomedicine) market manufacturers and aims to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis, and development plans in the next few years. Moreover, for forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end-user trends, and production capacity are taken into consideration. It also covers a short outline of the dealers, distributors, and suppliers.

ACCESS FULL REPORT: https://www.researchstore.biz/report/global-healthcare-nanotechnology-nanomedicine-market-2020-47548

Key Developments In The Market: This segment of the Healthcare Nanotechnology (Nanomedicine) market report combines the major developments of the market that contains confirmations, composed endeavors, R&D, joint endeavors, and the relationship of driving members working in the market. The anticipated growth rate expected to be recorded by each region over the estimated years has been given within the research report.

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Researchstore.biz is a fully dedicated global market research agency providing thorough quantitative and qualitative analysis of extensive market research.Our corporate is identified by recognition and enthusiasm for what it offers, which unites its staff across the world.We are desired market researchers proving a reliable source of extensive market analysis on which readers can rely on. Our research team consist of some of the best market researchers, sector and analysis executives in the nation, because of which Researchstore.biz is considered as one of the most vigorous market research enterprises. Researchstore.biz finds perfect solutions according to the requirements of research with considerations of content and methods. Unique and out of the box technologies, techniques and solutions are implemented all through the research reports.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.researchstore.biz

Go here to see the original:
Global Healthcare Nanotechnology (Nanomedicine) Market 2020 with (Covid-19) Impact Analysis: Business Outlook, Future Growth and Regional Forecasts...

Recommendation and review posted by Alexandra Lee Anderson

Coronavirus threat to global Healthcare Nanotechnology (Nanomedicine) Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type…

The Healthcare Nanotechnology (Nanomedicine) Market research report enhanced worldwide Coronavirus COVID19 impact analysis on the market size (Value, Production and Consumption), splits the breakdown (Data Status 2014-2020 and 6 Year Forecast From 2020 to 2026), by region, manufacturers, type and End User/application. This Healthcare Nanotechnology (Nanomedicine) market report covers the worldwide top manufacturers like (Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche, Celgene, Sanofi, Merck & Co, Biogen, Stryker, Gilead Sciences, Pfizer, 3M Company, Johnson & Johnson, Smith&Nephew, Leadiant Biosciences, Kyowa Hakko Kirin, Shire, Ipsen, Endo International) which including information such as: Capacity, Production, Price, Sales, Revenue, Shipment, Gross, Gross Profit, Import, Export, Interview Record, Business Distribution etc., these data help the consumer know about the Healthcare Nanotechnology (Nanomedicine) market competitors better. It covers Regional Segment Analysis, Type, Application, Major Manufactures, Healthcare Nanotechnology (Nanomedicine) Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Healthcare Nanotechnology (Nanomedicine)[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2041239

Healthcare Nanotechnology (Nanomedicine) Market report offers comprehensive assessment of 1) Executive Summary, 2) Market Overview, 3) Key Market Trends, 4) Key Success Factors, 5) Healthcare Nanotechnology (Nanomedicine) Market Demand/Consumption (Value or Size in US$ Mn) Analysis, 6) Healthcare Nanotechnology (Nanomedicine) Market Background, 7) Healthcare Nanotechnology (Nanomedicine) industry Analysis & Forecast 20202026 by Type, Application and Region, 8) Healthcare Nanotechnology (Nanomedicine) Market Structure Analysis, 9) Competition Landscape, 10) Company Share and Company Profiles, 11) Assumptions and Acronyms and, 12) Research Methodology etc.

Scope of Healthcare Nanotechnology (Nanomedicine) Market:It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.

Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Anticancer CNS Product Anti-infective Other

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Nanomedicine Nano Medical Devices Nano Diagnosis Other

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2041239

Geographically, the report includes the research on production, consumption, revenue, Healthcare Nanotechnology (Nanomedicine) market share and growth rate, and forecast (2020-2026) of the following regions:

Important Healthcare Nanotechnology (Nanomedicine) Market Data Available In This Report:

Strategic Recommendations, Forecast Growth Areasof the Healthcare Nanotechnology (Nanomedicine) Market.

Challengesfor the New Entrants,TrendsMarketDrivers.

Emerging Opportunities,Competitive Landscape,Revenue Shareof Main Manufacturers.

This Report Discusses the Healthcare Nanotechnology (Nanomedicine) MarketSummary; MarketScopeGives A BriefOutlineof theHealthcare Nanotechnology (Nanomedicine) Market.

Key Performing Regions (APAC, EMEA, Americas) Along With Their Major Countries Are Detailed In This Report.

Company Profiles, Product Analysis,Marketing Strategies, Emerging Market Segments and Comprehensive Analysis of Healthcare Nanotechnology (Nanomedicine) Market.

Healthcare Nanotechnology (Nanomedicine) Market ShareYear-Over-Year Growthof Key Players in Promising Regions.

What is the (North America, South America, Europe, Africa, Middle East, Asia, China, Japan)production, production value, consumption, consumption value, import and exportof Healthcare Nanotechnology (Nanomedicine) market?

To Get Discount of Healthcare Nanotechnology (Nanomedicine) Market:https://www.researchmoz.us/enquiry.php?type=D&repid=2041239

Contact:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Read more here:
Coronavirus threat to global Healthcare Nanotechnology (Nanomedicine) Market 2020 Industry Share, Size, Consumption, Growth, Top Manufacturers, Type...

Recommendation and review posted by Alexandra Lee Anderson

Global Nanomedicine Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players, Industry Updates, Future Growth, Business Prospects, In-depth…

Global Nanomedicine Market research report delivers comprehensive analysis of the market structure along with estimations of the various segments and sub-segments of the market. This study also analyzes the market status, market share, growth rate, sales volume, future trends, market drivers, market restraints, revenue generation, opportunities and challenges, risks and entry barriers, sales channels, and distributors. The company profiles of all the chief and dominating market players and brands who are taking steps such as product launches, joint ventures, mergers and acquisitions are mentioned in the report. With the use of SWOT analysis and Porters Five Forces analysis which are two of the standard, prominent and full-proof methods, this Global Nanomedicine Market report is been framed.

To prosper in this competitive market place, businesses consider taking up innovative solutions and market research report is one of them. Analysis and estimations derived through the enormous information gathered in this Global Nanomedicine market analysis report are extremely necessary when it comes to dominating the market or creating a mark in the market as a new emergent. A lot of efforts have been put together and no stone is left unturned while generating this report. This Global Nanomedicine market report represents a professional and all-inclusive study of the industry which focuses on primary and secondary drivers, market share, competitor analysis, leading segments and geographical analysis.

Global nanomedicine marketis registering a healthy CAGR of 15.50% in the forecast period of 2019-2026. This rise in the market value can be attributed to increasing number of applications and wide acceptance of the product globally. There is a significant rise in the number of researches done in this field which accelerate growth of nanomedicine market globally.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-market

Key Market Competitors

Few of the major market competitors currently working in the global nanomedicine market are Abbott, Invitae Corporation, General Electric Company, Leadiant Biosciences, Inc., Johnson & Johnson Services, Inc., Mallinckrodt, Merck Sharp & Dohme Corp., NanoSphere Health Sciences, Inc., Pfizer Inc., CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd., Gilead Sciences, Inc., Amgen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Luminex Corporation, Eli Lilly and Company, Nanobiotix, Sanofi, UCB S.A., Ablynx among others.

Competitive Landscape

Global nanomedicine market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of nanomedicine market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

Market Drivers are Restraints

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/request-a-discount/global-nanomedicine-market

To comprehend Global Nanomedicine market dynamics in the world mainly, the worldwide Nanomedicine market is analyzed across major global regions.

Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

For More Insights Get Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-market

Nanomedicine Market report effectively provides required features of the global market for the population and for the business looking people for mergers & acquisitions, making investments, new vendors or concerned in searching for the appreciated global market research facilities. It offers sample on the size, offer, and development rate of the market. The Nanomedicine report provides the complete structure and fundamental overview of the industry market.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Read the original here:
Global Nanomedicine Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players, Industry Updates, Future Growth, Business Prospects, In-depth...

Recommendation and review posted by Alexandra Lee Anderson

Nanomedicine Market Analysis, Top Manufacturers, Share, Growth, Statistics, Opportunities and Forecast To 2026 – Cole of Duty

New Jersey, United States,- A detailed research study on Nanomedicine Market recently published by Market Research Intellect. This is the latest report, which covers the time COVID-19 impact on the market. Pandemic Coronavirus (COVID-19) has affected every aspect of global life. This has brought some changes in market conditions. Rapidly changing market scenario and the initial assessment and the future of this effect is included in the report. Reports put together a brief analysis of the factors affecting the growth of the current business scenarios in various areas. Important information relating to the size of the industry analysis, sharing, application, and statistics summed up in the report to present the ensemble prediction. In addition, this report includes an accurate competitive analysis of major market players and their strategies during the projection period.

This report includes market size estimates for the value (million USD) and volume (K Units). Both top-down and bottom-up approach has been used to estimate the size of the market and validate the Market of Nanomedicine, to estimate the size of the various submarkets more dependent on the overall market. Key players in the market have been identified through secondary research and their market share has been determined through primary and secondary research. All the shares percentage, split, and the damage have been determined using secondary sources and primary sources verified.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=201321&utm_source=COD&utm_medium=888

Leading Nanomedicine manufacturers/companies operating at both regional and global levels:

Nanomedicine Market Competitive Landscape & Company Profiles

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the Nanomedicine market.

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Nanomedicine market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Nanomedicine Market, By Product

Nanomedicine Market, By Application

Regions Covered in these Report:

Asia Pacific (China, Japan, India, and Rest of Asia Pacific)Europe (Germany, the UK, France, and Rest of Europe)North America (the US, Mexico, and Canada)Latin America (Brazil and Rest of Latin America)Middle East & Africa (GCC Countries and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=201321&utm_source=COD&utm_medium=888

Nanomedicine Market Research Methodology

The research methodology adopted for the analysis of the market involves the consolidation of various research considerations such as subject matter expert advice, primary and secondary research. Primary research involves the extraction of information through various aspects such as numerous telephonic interviews, industry experts, questionnaires and in some cases face-to-face interactions. Primary interviews are usually carried out on a continuous basis with industry experts in order to acquire a topical understanding of the market as well as to be able to substantiate the existing analysis of the data.

Subject matter expertise involves the validation of the key research findings that were attained from primary and secondary research. The subject matter experts that are consulted have extensive experience in the market research industry and the specific requirements of the clients are reviewed by the experts to check for completion of the market study. Secondary research used for the Nanomedicine market report includes sources such as press releases, company annual reports, and research papers that are related to the industry. Other sources can include government websites, industry magazines and associations for gathering more meticulous data. These multiple channels of research help to find as well as substantiate research findings.

Table of Content

1 Introduction of Nanomedicine Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Nanomedicine Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Nanomedicine Market, By Deployment Model

5.1 Overview

6 Nanomedicine Market, By Solution

6.1 Overview

7 Nanomedicine Market, By Vertical

7.1 Overview

8 Nanomedicine Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Nanomedicine Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=201321&utm_source=COD&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Display Driver Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Floating Production Storage Offloading (Fpso) Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Mice Model Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Originally posted here:
Nanomedicine Market Analysis, Top Manufacturers, Share, Growth, Statistics, Opportunities and Forecast To 2026 - Cole of Duty

Recommendation and review posted by Alexandra Lee Anderson

Healthcare Nanotechnology (Nanomedicine) Market Analysis, Top Manufacturers, Share, Growth, Statistics, Opportunities and Forecast To 2026 – Cole of…

New Jersey, United States,- A detailed research study on Healthcare Nanotechnology (Nanomedicine) Market recently published by Market Research Intellect. This is the latest report, which covers the time COVID-19 impact on the market. Pandemic Coronavirus (COVID-19) has affected every aspect of global life. This has brought some changes in market conditions. Rapidly changing market scenario and the initial assessment and the future of this effect is included in the report. Reports put together a brief analysis of the factors affecting the growth of the current business scenarios in various areas. Important information relating to the size of the industry analysis, sharing, application, and statistics summed up in the report to present the ensemble prediction. In addition, this report includes an accurate competitive analysis of major market players and their strategies during the projection period.

This report includes market size estimates for the value (million USD) and volume (K Units). Both top-down and bottom-up approach has been used to estimate the size of the market and validate the Market of Healthcare Nanotechnology (Nanomedicine), to estimate the size of the various submarkets more dependent on the overall market. Key players in the market have been identified through secondary research and their market share has been determined through primary and secondary research. All the shares percentage, split, and the damage have been determined using secondary sources and primary sources verified.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=210503&utm_source=COD&utm_medium=888

Leading Healthcare Nanotechnology (Nanomedicine) manufacturers/companies operating at both regional and global levels:

Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape & Company Profiles

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the Healthcare Nanotechnology (Nanomedicine) market.

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Healthcare Nanotechnology (Nanomedicine) market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Healthcare Nanotechnology (Nanomedicine) Market, By Product

Healthcare Nanotechnology (Nanomedicine) Market, By Application

Regions Covered in these Report:

Asia Pacific (China, Japan, India, and Rest of Asia Pacific)Europe (Germany, the UK, France, and Rest of Europe)North America (the US, Mexico, and Canada)Latin America (Brazil and Rest of Latin America)Middle East & Africa (GCC Countries and Rest of Middle East & Africa)

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=210503&utm_source=COD&utm_medium=888

Healthcare Nanotechnology (Nanomedicine) Market Research Methodology

The research methodology adopted for the analysis of the market involves the consolidation of various research considerations such as subject matter expert advice, primary and secondary research. Primary research involves the extraction of information through various aspects such as numerous telephonic interviews, industry experts, questionnaires and in some cases face-to-face interactions. Primary interviews are usually carried out on a continuous basis with industry experts in order to acquire a topical understanding of the market as well as to be able to substantiate the existing analysis of the data.

Subject matter expertise involves the validation of the key research findings that were attained from primary and secondary research. The subject matter experts that are consulted have extensive experience in the market research industry and the specific requirements of the clients are reviewed by the experts to check for completion of the market study. Secondary research used for the Healthcare Nanotechnology (Nanomedicine) market report includes sources such as press releases, company annual reports, and research papers that are related to the industry. Other sources can include government websites, industry magazines and associations for gathering more meticulous data. These multiple channels of research help to find as well as substantiate research findings.

Table of Content

1 Introduction of Healthcare Nanotechnology (Nanomedicine) Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Healthcare Nanotechnology (Nanomedicine) Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Healthcare Nanotechnology (Nanomedicine) Market, By Deployment Model

5.1 Overview

6 Healthcare Nanotechnology (Nanomedicine) Market, By Solution

6.1 Overview

7 Healthcare Nanotechnology (Nanomedicine) Market, By Vertical

7.1 Overview

8 Healthcare Nanotechnology (Nanomedicine) Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Healthcare Nanotechnology (Nanomedicine) Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=210503&utm_source=COD&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Printed Cartons Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Printed Sensor Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Printing for Packaging Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the original post:
Healthcare Nanotechnology (Nanomedicine) Market Analysis, Top Manufacturers, Share, Growth, Statistics, Opportunities and Forecast To 2026 - Cole of...

Recommendation and review posted by Alexandra Lee Anderson

INBRAIN Neuroelectronics receives funding to push forward the development of graphene-based implants for brain disorders – Graphene-Info

INBRAIN Neuroelectronics, a spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2), the Barcelona Institute of Science and Technology (BIST) and ICREA, has received funding from Sabadell Asabys and Alta Life Sciences, as well as ICF and Finaves, which will allow the company to speed up the development of novel graphene-based implants to optimize the treatment of brain disorders, such as Parkinsons and epilepsy.

INBRAIN Neuroelectronics was established in 2019 with the mission of developing brain-implants based on graphene technology for application in patients with epilepsy, Parkinsons, and other neuronal diseases. These smart devices, built around an innovative graphene electrode, will decode with high certainty neural signals from the brain and produce a therapeutic response adapted to the clinical condition of the specific patient.

The company is designing the least invasive and smartest neural interface that, powered by artificial intelligence and the use of Big Data, will have the ability to read and modulate brain activity, detect specific biomarkers, and trigger adaptive responses to deliver optimal results in personalised neurological therapies. So far, the technology has been validated in in-vitro and in-vivo biocompatibility and toxicity tests and has been successfully used to complete studies on small animals. Recently, INBRAIN began tests on large animals with the aim of ensuring that these graphene devices are safe as well as superior to current solutions based on metals such as platinum and iridium. The company also plans to start human studies soon.

INBRAIN was founded, among others, by ICREA Prof. Jose Garrido, leader of the ICN2 Advanced Electronic Materials and Devices Group, Prof. Kostas Kostarelos, leader of the ICN2 Nanomedicine Group, and Dr. Anton Guimer, a researcher at the Spanish National Centre of Microelectronics (IMB-CNM).

Within the framework of the Graphene Flagship, which is a European macroproject, explains Prof. Garrido, we were able to develop this novel graphene-based technology that will allow measuring and stimulating neuronal activity in the brain with a resolution much higher than that of current commercial technologies.

Throughout 2019, the incorporation of INBRAIN was a priority project for the ICN2 Business and Innovation Department, which coordinated the technology transfer process and successfully orchestrated the licensing of this high-potential technology.

Minimally invasive electronic therapies represent a revolutionary alternative with less potential cost for health systems, comments Carolina Aguilar, CEO of INBRAIN and a former global executive at Medtronic in the field of neuro-stimulation. In our case, the application of new 2D materials such as graphene represents a real opportunity to understand the brain workings in order to optimise and personalize the treatment.

See original here:
INBRAIN Neuroelectronics receives funding to push forward the development of graphene-based implants for brain disorders - Graphene-Info

Recommendation and review posted by Alexandra Lee Anderson

Impact of COVID-19 on Nanomedicine Market Top Companies Analysis To growing at CAGR of 12.6% by 2023 – Cole of Duty

UPDATE AVAILABLE ON-DEMAND

Global Nanomedicine Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

The global nanomedicine market was valued at $111,912 million in 2016, and is projected to reach $261,063 million by 2023, growing at a CAGR of 12.6% from 2017 to 2023. The drug delivery segment accounted for nearly two-fifths share of the global market in 2016.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2021

Nanomedicine is an application of nanotechnology that deals in the prevention & treatment of diseases in humans. This technology uses submicrometer-sized particles for diagnosis, treatment, and prevention of diseases. Nanomedicines are advantageous over generic drugs in several aspects such as, to reduce renal excretion, improve the ability of drugs to accumulate at pathological sites, and enhance the therapeutic index of drugs. Thus, nanomedicine is used in a wide range of applications that include aerospace materials, cosmetics, and medicine.

The global market is driven by increase in the development of nanotechnology-based drugs, advantages of nanomedicine in various healthcare applications, and growth in need of therapies with fewer side effects. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth. In addition, growth of healthcare facilities in emerging economies is anticipated to provide numerous opportunities for the market growth.

The vaccines segment is expected to register a significant CAGR of 13.2% throughout the forecast period. The treatment segment accounted for about fourth-sevenths share in the global market in 2016, accounting for the highest share during the forecast period. This is due to the high demand for therapeutics among patient and rise in the incidence of chronic diseases.

The neurological diseases segment is expected to grow at the highest CAGR of 13.9% during the forecast period, owing to high demand for brain monitoring & treatment devices and drugs. The oncological diseases segment accounted for the highest revenue in 2016, with one-third share of the global market, and is expected to maintain its dominance throughout the forecast period.

In 2016, Asia-Pacific and LAMEA collectively accounted for about one-fourth share of the global market, and is expected to continue this trend due to increased adoption of nanomedicines, especially in China, India, and the other developing economies. In addition, rise in investments by key players in the field of nanomedicines is key driving factor of the Asia-Pacific market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2021

The Major Key Players Are:

The Other Prominent Players Are:

Similar Reports:

Healthcare Payer Solution Market Global Opportunity Analysis and Industry Forecast, 2020-2027

Pharmerging Market Global Opportunity Analysis and Industry Forecast, 2020-2027

HIV Diagnosis Market Global Opportunity Analysis and Industry Forecast, 2020-2027

Hybrid Imaging Market Global Opportunity Analysis and Industry Forecast, 2020-2027

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

Contact:

David CorreaPortland, OR, United StatesUSA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1(855)550-5975[emailprotected]Web:https://www.alliedmarketresearch.comFollow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

See original here:
Impact of COVID-19 on Nanomedicine Market Top Companies Analysis To growing at CAGR of 12.6% by 2023 - Cole of Duty

Recommendation and review posted by Alexandra Lee Anderson


Page 21234..1020..»